跳转至内容
Merck
CN

13433

Sigma-Aldrich

碳酸氢钠

puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder

别名:

碳酸氢钠, 小苏打

登录查看公司和协议定价


About This Item

线性分子式:
NaHCO3
CAS号:
分子量:
84.01
Beilstein:
4153970
EC 号:
MDL编号:
UNSPSC代码:
12352302
eCl@ss:
38020213
PubChem化学物质编号:
NACRES:
NA.21
方案:
99.0-100.5%
表单:
powder

等级

puriss.

质量水平

方案

99.0-100.5%

表单

powder

质量

meets analytical specification of Ph. Eur., BP, USP, FCC, E500

杂质

ammonia (NH3), in accordance
organic volatile impurities, complies
residual solvents, complies
water-insoluble matter, complies
≤0.002% ammonium (NH4), complies

缺失

≤0.2% loss on drying (silica gel)

pH值(酸碱度)

≤8.6 (20 °C, 5%)

pKa (25 °C)

(1) 6.37, (2) 10.25 (carbonic acid)

密度

2.16 g/mL at 25 °C (lit.)

痕量阴离子

carbonate (CO32-): in accordance
chloride (Cl-): ≤100 mg/kg
sulfate (SO42-): ≤100 mg/kg

痕量阳离子

Al: ≤0.5 mg/kg
As: ≤2 mg/kg
Ca: ≤100 mg/kg
Fe: ≤10 mg/kg
Hg: ≤1 mg/kg
K: ≤100 mg/kg
Pb: ≤2 mg/kg

适用性

complies for appearance of solution

SMILES字符串

[Na+].OC([O-])=O

InChI

1S/CH2O3.Na/c2-1(3)4;/h(H2,2,3,4);/q;+1/p-1

InChI key

UIIMBOGNXHQVGW-UHFFFAOYSA-M

正在寻找类似产品? 访问 产品对比指南

应用

碳酸氢钠可能参与基于二氧化硅的整体柱的制造,可用于毛细管电色谱。也可用于通过离子交换置换色谱法维持色谱柱的 pH 值,用于蛋白质的分离。

储存分类代码

13 - Non Combustible Solids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Silica-based monoliths for capillary electrochromatography: Methods of fabrication and their applications in analytical separations
Allen D and Rassi EZ
Electrophoresis, 24, 3962-3976 (2003)
Use of the sodium salt of poly (vinylsulfonic acid) as a low-molecular-weight displacer for protein separations by ion-exchange displacement chromatography
Jen D.C.S and Pinto.GN
Journal of Chromatography A, 519(1), 87-98 (1990)
Shay P McGuinness et al.
Critical care medicine, 41(7), 1599-1607 (2013-05-21)
Cardiac surgery-associated acute kidney injury occurs in up to 50% of patients and is associated with increased mortality and morbidity. This study aimed to discover if perioperative urinary alkalinization with sodium bicarbonate infusion reduces the prevalence of cardiac surgery-associated acute
Sophia Zoungas et al.
Annals of internal medicine, 151(9), 631-638 (2009-11-04)
Intravenous sodium bicarbonate has been proposed to reduce the risk for contrast-induced nephropathy (CIN). To determine the effect of sodium bicarbonate on the risk for CIN. MEDLINE, PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from 1950 to
Eric A J Hoste et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25(3), 747-758 (2009-08-26)
There have been conflicting reports on the use of intravenous administration of sodium bicarbonate for prevention of contrast-induced acute kidney injury (CI-AKI). The aim of this study was to evaluate the use of sodium bicarbonate for prevention of CI-AKI. This

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门